Robert E MacLaren
Overview
Explore the profile of Robert E MacLaren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
332
Citations
6241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
12.
Borchert G, Shanks M, Whitfield J, Clouston P, Raji S, Sperring S, et al.
Ophthalmic Genet
. 2024 Sep;
45(6):633-639.
PMID: 39232248
Background: (Cilia and Flagella Associated Protein 410) encodes a protein that has an important role in the development and function of cilia. In ophthalmology, pathogenic variants in have been described...
13.
Quinn J, Salman A, Paluch C, Jackson-Wood M, McClements M, Luo J, et al.
Sci Rep
. 2024 Aug;
14(1):20033.
PMID: 39198470
Uveitis is characterised by breakdown of the blood-retinal barrier (BRB), allowing infiltration of immune cells that mediate intraocular inflammation, which can lead to irreversible damage of the neuroretina and the...
14.
Ie A, Sagoo M, MacLaren R, Cehajic-Kapetanovic J
Ocul Oncol Pathol
. 2024 Aug;
10(3):175-181.
PMID: 39171206
Introduction: Retinal focal nodular gliosis (FNG), also known as vasoproliferative tumors (VPTs), are rare, benign vascular tumors associated with exudation with no current consensus on management. Herein, we describe the...
15.
Ng B, Kaukonen M, McClements M, Shamsnajafabadi H, MacLaren R, Cehajic-Kapetanovic J
Prog Retin Eye Res
. 2024 Aug;
102:101289.
PMID: 39127142
Conventional gene therapy involving supplementation only treats loss-of-function diseases and is limited by viral packaging sizes, precluding therapy of large genes. The discovery of CRISPR/Cas has led to a paradigm...
16.
Gocuk S, Ayton L, Edwards T, McGuinness M, MacLaren R, Taylor L, et al.
Br J Ophthalmol
. 2024 Aug;
109(2):293-299.
PMID: 39122355
Background/aims: Female choroideremia carriers present with a spectrum of disease severity. Unlike in men, the rate of disease progression has not been well characterised in carriers. This longitudinal study aimed...
17.
Borchert G, Shamsnajafabadi H, Ng B, Xue K, de Silva S, Downes S, et al.
Front Neurosci
. 2024 Jul;
18:1415575.
PMID: 39010943
Age-related macular degeneration (AMD) is a growing public health concern given the aging population and it is the leading cause of blindness in developed countries, affecting individuals over the age...
18.
Baffour-Awuah K, Taylor L, Josan A, Jolly J, MacLaren R
Ophthalmic Physiol Opt
. 2024 Jul;
44(6):1188-1201.
PMID: 38989810
Introduction: Degeneration in choroideremia, unlike typical centripetal photoreceptor degenerations, is centred temporal to the fovea. Once the fovea is affected, the nasal visual field (temporal retina) is relatively spared, and...
19.
MacLaren R, Audo I, Fischer M, Huckfeldt R, Lam B, Pennesi M, et al.
Hum Gene Ther
. 2024 Jul;
35(15-16):564-575.
PMID: 38970425
Choroideremia, an incurable, progressive retinal degeneration primarily affecting young men, leads to sight loss. GEMINI was a multicenter, open-label, prospective, two-period, interventional Phase II study assessing the safety of bilateral...
20.
Mi H, MacLaren R, Cehajic-Kapetanovic J
Eye (Lond)
. 2024 Jul;
39(4):673-682.
PMID: 38965320
The use of robotic surgery in ophthalmology has been shown to offer many potential advantages to current surgical techniques. Vitreoretinal surgery requires complex manoeuvres and high precision, and this is...